In Managed Care’s Perspective: Best Practices in Payer-Manufacturer Relationships, RG+A explores the relationship between payers and manufacturers from the perspective of managed care professionals. Using original research from RG+A’s Health Payer Council, we illustrate key differences between contracting and partnership, and the general perceptions that payers have when engaging with biopharma manufacturers.
This presentation discusses the following topics:
- Drivers and barriers to successful relationships between managed care and manufacturers of oncology agents
- Evolving approaches to managing high-cost oncologics as costs of agents rise and combination therapies become more the norm
- Perceptions, attitudes and behaviors that drive successful plan-manufacturer relationships
- Beliefs of payers believe on the value provided by their favorite companies, brands, and account teams